Suchergebnisse - "Jang, Jun Ho"

PubPharm (18)

1

Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA) : a double-blind, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Lee, J. | Griffin, M. | Kim, J. | +67

2

Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy : Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial

enthalten in: American journal of hematology | 2023

von Wei, A. | Döhner, H. | Sayar, H. | +15

3

Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria : a 2-cohort open-label proof-of-concept study

enthalten in: Blood advances | 2022

von Jang, J. | Wong, L. | Ko, B. | +7

4

Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke : A Neuroimaging Study

enthalten in: Stroke | 2022

von Lee, J. | Chang, W. | Chung, J. | +19

5

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission : results from the phase 3, placebo-controlled QUAZAR AML-001 trial

enthalten in: Haematologica | 2021

von Roboz, G. | Döhner, H. | Pocock, C. | +19

6

Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke

enthalten in: Neurology | 2021

von Chung, J. | Chang, W. | Bang, O. | +20

CommentIn: Neurology. 2021 Feb 16;96(7):301-302. - PMID 33472923

7

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

enthalten in: The New England journal of medicine | 2020

von Wei, A. | Döhner, H. | Pocock, C. | +127

CommentIn: Nat Rev Clin Oncol. 2021 Mar;18(3):132. - PMID 33462426

8

Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy : a dose-finding and long-term treatment phase 2 trial

enthalten in: The Lancet. Haematology | 2019

von Lee, J. | Lee, S. | Jung, C. | +6

CommentIn: Lancet Haematol. 2019 Nov;6(11):e543-e544. - PMID 31474547

9

Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia : a randomised, double-blind, phase 2 study

enthalten in: The Lancet. Haematology | 2019

von Frey, N. | Jang, J. | Szer, J. | +12

10

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

enthalten in: BMC cancer | 2017

von Seymour, J. | Döhner, H. | Butrym, A. | +18